FDA and EMA Finalize Guidances to Help in Postapproval Change Management
May 31st, 2014
Please Log in to print the full article
FDA and EMA have issued final guidances intended to help industry better understand and manage the regulatory expectations for postapproval CMC changes.......
You must be a paid subscriber to continue reading this article. If you are a paid subscriber, please Log in. If you are not a paid subscriber, please subscribe now.